During the past decade, CSSS-Institut Universitaire Gériatric de Sherbrooke conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CSSS-Institut Universitaire Gériatric de Sherbrooke" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Fonds de la Recherche en Santé du Québec" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CSSS-Institut Universitaire Gériatric de Sherbrooke" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "CSSS-Institut Universitaire Gériatric de Sherbrooke" in a lesser frequency.

Most popular intervention types in "CSSS-Institut Universitaire Gériatric de Sherbrooke" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BI 409306" (2 trials), "Lanabecestat" (2 trials), "Donepezil" (1 trials) and "calorie controlled diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "CSSS-Institut Universitaire Gériatric de Sherbrooke" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CSSS-Institut Universitaire Gériatric de Sherbrooke". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CSSS-Institut Universitaire Gériatric de Sherbrooke, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CSSS-Institut Universitaire Gériatric de Sherbrooke, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".